Overview

Clinical Study of Solifenacin Succinate in Patients With Bladder Symptoms Due to Spinal Cord Injury or Multiple Sclerosis

Status:
Completed
Trial end date:
2011-01-28
Target enrollment:
Participant gender:
Summary
A clinical study to evaluate the efficacy and safety of solifenacin in patients with bladder symptoms due to spinal cord injury or multiple sclerosis
Phase:
Phase 4
Details
Lead Sponsor:
Astellas Pharma Inc
Treatments:
Mandelic Acids
Oxybutynin
Solifenacin Succinate